| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Instituto Nacional de la Nutricion, Mexico City, Tlalpan, Mexico
2 Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States
3 Dept. Anesthesiology Res. Div., Vanderbilt University Med. Ctr., Nashville, Tennessee, United States
4 Instituto Nacional de la Nutricion, Mexico City, Tlalpan, Mexico; Dept de Nefrologia y Metabolismo Mineral, Inst Nacional de la Nutrition Salvador Zubiran, Mexico, D.F., Mexico; , Instituto de Investigaciones Biomedicas, UNAM, Mexico
* To whom correspondence should be addressed. E-mail: gamba{at}biomedicas.unam.mx.
WNK kinases (with no lysine (K) kinase) are emerging as regulators of several membrane transport proteins in which WNKs act as molecular switches that coordinate the activity of several players. Members of the cation-coupled chloride cotransporters family (Solute Carrier Family number 12) are one of the main targets. WNK3 activates the Na+-driven cotransporters NCC, NKCC1, and NKCC2 and inhibits the K+-driven cotransporters KCC1 to KCC4. WNK4 inhibits the activity of NCC and NKCC1, while in the presence of the STE20-related proline-alanine rich kinase SPAK activates NKCC1. Nothing is known, however, regarding the effect of WNK4 upon the K+-Cl- cotransporters. Using the heterologous expression system of Xenopus laevis oocytes, here we show that WNK4 inhibits the activity of the K+-Cl- cotransporters KCC1, KCC3, and KCC4 under cell swelling, a condition in which these cotransporters are maximally active. The effect of WNK4 requires its catalytic activity because it was lost by the substitution of aspartate 318 for alanine (WNK4-D318A) that renders WNK4 catalytically inactive. In contrast, three different WNK4 missense mutations that cause pseudohypoaldosteronism type II do not affect the WNK4-induced inhibition of KCC4. Finally, we observed that catalytically inactive WNK4-D318A is able to bypass the tonicity requirements for KCC2 and KCC3 activation in isotonic conditions. This effect is enhanced by the presence of catalytically inactive SPAK, it was prevented by the presence of protein phosphatases inhibitors, and was not present in KCC1 and KCC4. Our results reveal that WNK4 regulates the activity of the K+-Cl- cotransporters expressed in the kidney.
This article has been cited by other articles:
|
|
 |
|
  G. Gamba The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional properties, and regulation by WNKs Am J Physiol Renal Physiol, October 1, 2009; 297(4): F838 - F848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. Lambert, T. K. Klausen, A. Bergdahl, C. Hougaard, and E. K. Hoffmann ROS activate KCl cotransport in nonadherent Ehrlich ascites cells but K+ and Cl- channels in adherent Ehrlich Lettre and NIH3T3 cells Am J Physiol Cell Physiol, July 1, 2009; 297(1): C198 - C206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. San-Cristobal, D. Pacheco-Alvarez, C. Richardson, A. M. Ring, N. Vazquez, F. H. Rafiqi, D. Chari, K. T. Kahle, Q. Leng, N. A. Bobadilla, et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway PNAS, March 17, 2009; 106(11): 4384 - 4389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen Physiology of Cell Volume Regulation in Vertebrates Physiol Rev, January 1, 2009; 89(1): 193 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, T. Na, and J.-B. Peng WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1472 - F1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Richardson and D. R. Alessi The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway J. Cell Sci., October 15, 2008; 121(20): 3293 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. San-Cristobal, J. Ponce-Coria, N. Vazquez, N. A. Bobadilla, and G. Gamba WNK3 and WNK4 amino-terminal domain defines their effect on the renal Na+-Cl- cotransporter Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1199 - F1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-B. Peng and D. G. Warnock WNK4-mediated regulation of renal ion transport proteins Am J Physiol Renal Physiol, October 1, 2007; 293(4): F961 - F973. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
